
SynBioBeta 2026 Speaker
Adrian Woolfson
Genyro
President & CEO
Adrian Woolfson is the co-founder of Genyro, a California-based biotechnology company specialising in AI-augmented synthetic genome design and construction. Born in London, he studied medicine at Balliol College, Oxford, molecular genetics at Gonville and Caius College Cambridge, and was formerly the Charles and Katherine Darwin Research Fellow at Darwin College, Cambridge, where he worked with Nobel Prize Winer Cรฉsar Milstein in the Division of Protein and Nucleic Acid Chemistry at the MRC Laboratory of Molecular Biology. He is the author of the critically acclaimed Life Without Genes: The History and Future of Genomes, An Intelligent Personโs Guide to Genetics, and On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence. He has authored over 160 scientific papers, book chapters, reviews, and patents, contributed to multiple publications including the Washington Post, Nature, The Spectator, The Literary Review, Prospect Magazine, The Times Literary Supplement, London Review of Books, and Financial Times, and is a regular contributor to the Wall Street Journal and Science magazine. He currently lives in San Francisco.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


